首頁 > 市場調查報告書 > 食物/飲料

調味料

市場調查報告書

商品編碼

1524318

塔格糖市場規模 - 按類型（L-塔格糖、D-塔格糖）應用（食品和飲料、藥品、個人護理、動物飼料、其他）配銷通路（線上零售、專賣店、直銷）和預測，2024 - 2032

Tagatose Market Size - By Type (L-Tagatose, D-tagatose) Application (Food & beverages, Pharmaceuticals, Personal care, Animal Feed, Others) Distribution Channel (Online retail, Specialty store, Direct sales) & Forecast, 2024 - 2032

出版日期: 2024年04月17日 | 出版商:

Global Market Insights Inc. | 英文 305 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在健康意識不斷提升的推動下，全球塔格糖市場預計 2024 年至 2032 年間複合年成長率將超過 4.7%。人們對健康益處的認知不斷提高以及對低熱量甜味劑的需求是市場的關鍵催化劑。這種天然甜味劑以其低熱量和益生元特性而聞名，擴大用於食品和飲料行業。不斷增加的糖尿病負擔正在推動預測期內對塔格糖的需求。根據 IDF 糖尿病圖譜，10.5% 的成年人（20-79 歲）患有糖尿病，其中近一半人不知道自己的病情。預計到 2045 年，每 8 名成年人中就有 1 人（即約 7.83 億人）患有糖尿病，增幅為 46%。

糖尿病患者需要低升糖指數的替代品，並發現塔格糖適合食用。生產技術的進步也使塔格糖更具成本效益，而消費者對天然成分的偏好和功能性食品的興起開闢了新的市場途徑。這些因素共同加強了塔格糖市場的成長。

整個塔格糖產業根據類型、應用、配銷通路和地區進行分類。

由於其潛在的治療功效，到 2032 年，製藥領域將佔據重要的塔格糖市場。其益生元特性可增強腸道健康，支持其在消化保健補充劑中的應用。此外，塔格糖在控制高血糖和代謝紊亂方面顯示出前景，這使其對於糖尿病相關的治療很有價值。其低升糖指數和對血糖值的影響極小，使其成為糖尿病患者藥物中的安全成分。對塔格糖抗氧化和抗發炎特性的持續研究表明其在更廣泛的製藥應用中的潛力，從而迎來了對其的需求。

L-塔格糖細分市場從 2024 年到 2032 年將呈現出有希望的複合年成長率，因為其獨特的代謝途徑使其能夠被人體最小化吸收，從而降低血糖水平。這一特性使其非常適合體重管理和肥胖預防。此外，L-塔格糖天然存在於乳製品和水果中，吸引了尋求正宗、加工較少成分的消費者。由於其非致齲性，隨著消費者越來越重視口腔健康和整體福祉，其在牙齒保健產品中的應用增加了其需求。

由於人們越來越關注永續和天然成分，歐洲塔格糖市場將在 2032 年蓬勃發展，其 CGAR 值得關注。歐洲消費者的健康意識越來越強，因此更偏好塔格糖等低熱量和低血糖甜味劑。此外，對人造甜味劑的嚴格監管以及對清潔標籤產品的大力推動促使製造商選擇天然替代品。歐洲功能性食品和飲料市場的不斷升級促進了需求，因為塔格糖符合增強健康成分的趨勢。

產業生態系統分析
- 價值鏈
- 主要製造商
- 前往市場路線
- 主要經銷商
  - 新的分銷管道
- 全行業利潤率
產業影響力
- 成長動力
  - 對天然成分的需求
  - 增強健康意識
  - 產品創新及多元化
- 產業陷阱與挑戰
  - 來自現有甜味劑的競爭
  - 生產成本高
- 市場機會
  - 新市場/新應用
  - 成長潛力分析
原料景觀
- 製造趨勢
  - 技術演進
  - 永續製造
    - 綠色實踐
    - 脫碳
- 新原料
- 原物料價格走勢（美元/噸）
  - 美國
  - 歐洲聯盟
  - 英國
  - 中國
  - 東南亞
  - 海灣合作理事會
法規和市場影響
貿易統計
未滿足的需求
波特的分析
PESTEL分析

第 4 章：競爭格局

公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場規模與預測：按類型，2021-2032

主要趨勢
L-塔格糖
D-塔格糖

第 6 章：市場規模與預測：按應用分類，2021-2032 年

主要趨勢
食品與飲品
製藥
個人護理
動物飼料
其他

第 7 章：市場規模與預測：按配銷通路，2021-2032 年

主要趨勢
網路零售
專賣店
直銷

第 8 章：市場規模與預測：按地區分類，2021-2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
MEA
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
- MEA 的其餘部分

第 9 章：公司簡介

Alfa chemistry
Bio sugar technology
BLD pharm
Bonumose LLC
Chemily glycosciece
Merck
Ottokemi pvt ltd
Santa cruz biotechnology
Spectrum chemical
Syngars
Tokyo Chemical Industry
Zhejiang yixin pharamceutical co ltd

簡介目錄

Product Code: 9086

Global Tagatose Market will infer over 4.7% CAGR between 2024 and 2032, driven by escalating health consciousness. Rising awareness of health benefits and the demand for low-calorie sweeteners are key catalysts of the market. This natural sweetener, known for its low caloric content and prebiotic properties, is increasingly used in the food and beverage industry. The ever-growing burden of diabetes is propelling the demand for tagatose during the forecast period. As per the IDF Diabetes Atlas, 10.5% of adults (20-79 years) have diabetes, with nearly half unaware of their condition. By 2045, projections indicate that 1 in 8 adults, or about 783 million, will have diabetes, a 46% increase.

Diabetic people require low glycemic index alternatives and find Tagatose suitable for consumption. Technological advancements in production have also made Tagatose more cost-effective, while consumer preference for natural ingredients and the rise of functional foods have opened new market avenues. These factors collectively strengthen the growth of the tagatose market.

The overall tagatose industry is sorted based on type, application, distribution channel, and region.

The pharmaceuticals segment will clutch a significant tagatose market share by 2032 because of its potential therapeutic benefits. Its prebiotic properties enhance gut health, supporting its use in digestive health supplements. Additionally, Tagatose shows promise in managing hyperglycemia and metabolic disorders, making it valuable for diabetes-related treatments. Its low glycemic index and minimal impact on blood sugar levels make it a safe ingredient in medications for diabetic patients. Ongoing research into Tagatose's antioxidant and anti-inflammatory properties suggests its potential in broader pharmaceutical applications, ushering in its demand.

The L-Tagatose segment will exhibit a promising CAGR from 2024 to 2032, owing to its unique metabolic pathway, which allows it to be minimally absorbed by the body, resulting in lower blood sugar levels. This characteristic makes it highly desirable for weight management and obesity prevention. Additionally, L-Tagatose's natural occurrence in dairy products and fruits appeals to consumers seeking authentic, less processed ingredients. Due to its non-cariogenic nature, its application in dental health products boosts its demand as consumers increasingly prioritize oral health and overall well-being.

Europe tagatose market thrives with a noteworthy CGAR through 2032 due to the increasing focus on sustainable and natural ingredients. European consumers are becoming more health-conscious, leading to a higher preference for low-calorie and low-glycemic sweeteners like Tagatose. Additionally, stringent regulations on artificial sweeteners and a strong push towards clean-label products proliferate manufacturers to opt for natural alternatives. The escalating market for functional foods and beverages in Europe contributes to the demand, as Tagatose aligns with trends for health-enhancing ingredients.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Data Mining sources
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis
2.2 Type trends
2.3 Application trends
2.4 Distribution channel trends

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Value chain
- 3.1.2 Key manufacturers
- 3.1.3 Go to market routes
- 3.1.4 Key distributors
  - 3.1.4.1 New distribution channels
- 3.1.5 Profit margins across the industry
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Demand for natural ingredients
  - 3.2.1.2 Increasing health consciousness
  - 3.2.1.3 Product innovation and diversification
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1. Competition from existing sweeteners
  - 3.2.2.2. High production cost
- 3.2.3 Market opportunities
  - 3.2.3.1 New markets/applications
  - 3.2.3.2 Growth potential analysis
3.3 Raw material landscape
- 3.3.1 Manufacturing trends
  - 3.3.1.1 Technology evolution
  - 3.3.1.2 Sustainable manufacturing
    - 3.3.1.2.1 Green practices
    - 3.3.1.2.2 Decarbonization
- 3.3.2 New raw materials
- 3.3.3 Raw material pricing trends (USD/Ton)
  - 3.3.3.1 U.S.
  - 3.3.3.2 European Union
  - 3.3.3.3 UK
  - 3.3.3.4 China
  - 3.3.3.5 Southeast Asia
  - 3.3.3.6 GCC
3.4 Regulations & market impact
3.5 Trade statistics
3.6 Unmet needs
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Company market share analysis
4.2 Competitive positioning matrix
4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Type, 2021-2032 (USD Million, Kilo Tons)

5.1 Key trends
5.2 L-Tagatose
5.3 D-Tagatose

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

6.1 Key trends
6.2 Food and beverage
6.3 Pharmaceutical
6.4 Personal care
6.5 Animal feed
6.6 Other

Chapter 7 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Million, Kilo Tons)

7.1 Key trends
7.2 Online retail
7.3 Specialty store
7.4 Direct sale

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 MEA
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 South Africa
- 8.6.4 Rest of MEA